Exact Mass: 811.6148119999999

PC(16:1(9Z)/22:2(13Z,16Z))

C46H86NO8P (811.6090726)

PC(16:1(9Z)/22:2(13Z,16Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(16:1(9Z)/22:2(13Z,16Z)), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of docosadienoic acid at the C-2 position. The palmitoleic acid moiety is derived from animal fats and vegetable oils, while the docosadienoic acid moiety is derived from animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(16:1(9Z)/22:2(13Z,16Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(16:1(9Z)/22:2(13Z,16Z)), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of docosadienoic acid at the C-2 position. The palmitoleic acid moiety is derived from animal fats and vegetable oils, while the docosadienoic acid moiety is derived from animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PC(18:0/20:3)

C46H86NO8P (811.6090726)

PC(18:0/20:3(5Z,8Z,11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:0/20:3(5Z,8Z,11Z)), in particular, consists of one chain of stearic acid at the C-1 position and one chain of mead acid at the C-2 position. The stearic acid moiety is derived from animal fats, coco butter and sesame oil, while the mead acid moiety is derived from fish oils, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(18:0/20:3(8Z,11Z,14Z))

C46H86NO8P (811.6090726)

PC(18:0/20:3(8Z,11Z,14Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:0/20:3(8Z,11Z,14Z)), in particular, consists of one chain of stearic acid at the C-1 position and one chain of homo-g-linolenic acid at the C-2 position. The stearic acid moiety is derived from animal fats, coco butter and sesame oil, while the homo-g-linolenic acid moiety is derived from fish oils, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(18:1(11Z)/20:2(11Z,14Z))

C46H86NO8P (811.6090726)

PC(18:1(11Z)/20:2(11Z,14Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:1(11Z)/20:2(11Z,14Z)), in particular, consists of one chain of vaccenic acid at the C-1 position and one chain of eicosadienoic acid at the C-2 position. The vaccenic acid moiety is derived from butter fat and animal fat, while the eicosadienoic acid moiety is derived from fish oils and liver. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(18:1(9Z)/20:2(11Z,14Z))

C46H86NO8P (811.6090726)

PC(18:1(9Z)/20:2(11Z,14Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:1(9Z)/20:2(11Z,14Z)), in particular, consists of one chain of oleic acid at the C-1 position and one chain of eicosadienoic acid at the C-2 position. The oleic acid moiety is derived from vegetable oils, especially olive and canola oil, while the eicosadienoic acid moiety is derived from fish oils and liver. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(18:2(9Z,12Z)/20:1(11Z))

C46H86NO8P (811.6090726)

PC(18:2(9Z,12Z)/20:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:2(9Z,12Z)/20:1(11Z)), in particular, consists of one chain of linoleic acid at the C-1 position and one chain of eicosenoic acid at the C-2 position. The linoleic acid moiety is derived from seed oils, while the eicosenoic acid moiety is derived from vegetable oils and cod oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(18:2(9Z,12Z)/20:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:2(9Z,12Z)/20:1(11Z)), in particular, consists of one chain of linoleic acid at the C-1 position and one chain of eicosenoic acid at the C-2 position. The linoleic acid moiety is derived from seed oils, while the eicosenoic acid moiety is derived from vegetable oils and cod oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PC(18:3(6Z,9Z,12Z)/20:0)

C46H86NO8P (811.6090726)

PC(18:3(6Z,9Z,12Z)/20:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:3(6Z,9Z,12Z)/20:0), in particular, consists of one chain of g-linolenic acid at the C-1 position and one chain of arachidic acid at the C-2 position. The g-linolenic acid moiety is derived from animal fats, while the arachidic acid moiety is derived from peanut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(18:3(9Z,12Z,15Z)/20:0)

C46H86NO8P (811.6090726)

PC(18:3(9Z,12Z,15Z)/20:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:3(9Z,12Z,15Z)/20:0), in particular, consists of one chain of a-linolenic acid at the C-1 position and one chain of arachidic acid at the C-2 position. The a-linolenic acid moiety is derived from seed oils, especially canola and soybean oil, while the arachidic acid moiety is derived from peanut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(20:0/18:3(6Z,9Z,12Z))

C46H86NO8P (811.6090726)

PC(20:0/18:3(6Z,9Z,12Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(20:0/18:3(6Z,9Z,12Z)), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of g-linolenic acid at the C-2 position. The arachidic acid moiety is derived from peanut oil, while the g-linolenic acid moiety is derived from animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(20:0/18:3(6Z,9Z,12Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(20:0/18:3(6Z,9Z,12Z)), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of g-linolenic acid at the C-2 position. The arachidic acid moiety is derived from peanut oil, while the g-linolenic acid moiety is derived from animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PC(20:0/18:3(9Z,12Z,15Z))

C46H86NO8P (811.6090726)

PC(20:0/18:3(9Z,12Z,15Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(20:0/18:3(9Z,12Z,15Z)), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of a-linolenic acid at the C-2 position. The arachidic acid moiety is derived from peanut oil, while the a-linolenic acid moiety is derived from seed oils, especially canola and soybean oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(20:1(11Z)/18:2(9Z,12Z))

C46H86NO8P (811.6090726)

PC(20:1(11Z)/18:2(9Z,12Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(20:1(11Z)/18:2(9Z,12Z)), in particular, consists of one chain of eicosenoic acid at the C-1 position and one chain of linoleic acid at the C-2 position. The eicosenoic acid moiety is derived from vegetable oils and cod oils, while the linoleic acid moiety is derived from seed oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(20:2(11Z,14Z)/18:1(11Z))

C46H86NO8P (811.6090726)

PC(20:2(11Z,14Z)/18:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(20:2(11Z,14Z)/18:1(11Z)), in particular, consists of one chain of eicosadienoic acid at the C-1 position and one chain of vaccenic acid at the C-2 position. The eicosadienoic acid moiety is derived from fish oils and liver, while the vaccenic acid moiety is derived from butter fat and animal fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(20:2(11Z,14Z)/18:1(9Z))

C46H86NO8P (811.6090726)

PC(20:2(11Z,14Z)/18:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(20:2(11Z,14Z)/18:1(9Z)), in particular, consists of one chain of eicosadienoic acid at the C-1 position and one chain of oleic acid at the C-2 position. The eicosadienoic acid moiety is derived from fish oils and liver, while the oleic acid moiety is derived from vegetable oils, especially olive and canola oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(20:3(5Z,8Z,11Z)/18:0)

C46H86NO8P (811.6090726)

PC(20:3(5Z,8Z,11Z)/18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(20:3(5Z,8Z,11Z)/18:0), in particular, consists of one chain of mead acid at the C-1 position and one chain of stearic acid at the C-2 position. The mead acid moiety is derived from fish oils, liver and kidney, while the stearic acid moiety is derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(20:3(8Z,11Z,14Z)/18:0)

C46H86NO8P (811.6090726)

PC(20:3(8Z,11Z,14Z)/18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(20:3(8Z,11Z,14Z)/18:0), in particular, consists of one chain of homo-g-linolenic acid at the C-1 position and one chain of stearic acid at the C-2 position. The homo-g-linolenic acid moiety is derived from fish oils, liver and kidney, while the stearic acid moiety is derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(22:2(13Z,16Z)/16:1(9Z))

C46H86NO8P (811.6090726)

PC(22:2(13Z,16Z)/16:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(22:2(13Z,16Z)/16:1(9Z)), in particular, consists of one chain of docosadienoic acid at the C-1 position and one chain of palmitoleic acid at the C-2 position. The docosadienoic acid moiety is derived from animal fats, while the palmitoleic acid moiety is derived from animal fats and vegetable oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PE(24:1(15Z)/P-18:1(11Z))

C47H90NO7P (811.645456)

PE(24:1(15Z)/P-18:1(11Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(24:1(15Z)/P-18:1(11Z)), in particular, consists of one chain of nervonic acid at the C-1 position and one chain of plasmalogen 18:1n7 at the C-2 position. The nervonic acid moiety is derived from fish oils, while the plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PE(24:1(15Z)/P-18:1(11Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(24:1(15Z)/P-18:1(11Z)), in particular, consists of one chain of nervonic acid at the C-1 position and one chain of plasmalogen 18:1n7 at the C-2 position. The nervonic acid moiety is derived from fish oils, while the plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PE(24:1(15Z)/P-18:1(9Z))

C47H90NO7P (811.645456)

PE(24:1(15Z)/P-18:1(9Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(24:1(15Z)/P-18:1(9Z)), in particular, consists of one chain of nervonic acid at the C-1 position and one chain of plasmalogen 18:1n9 at the C-2 position. The nervonic acid moiety is derived from fish oils, while the plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PE(24:1(15Z)/P-18:1(9Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(24:1(15Z)/P-18:1(9Z)), in particular, consists of one chain of nervonic acid at the C-1 position and one chain of plasmalogen 18:1n9 at the C-2 position. The nervonic acid moiety is derived from fish oils, while the plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PE(P-18:1(11Z)/24:1(15Z))

C47H90NO7P (811.645456)

PE(P-18:1(11Z)/24:1(15Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-18:1(11Z)/24:1(15Z)), in particular, consists of one chain of plasmalogen 18:1n7 at the C-1 position and one chain of nervonic acid at the C-2 position. The plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney, while the nervonic acid moiety is derived from fish oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PE(P-18:1(11Z)/24:1(15Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-18:1(11Z)/24:1(15Z)), in particular, consists of one chain of plasmalogen 18:1n7 at the C-1 position and one chain of nervonic acid at the C-2 position. The plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney, while the nervonic acid moiety is derived from fish oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PE(P-18:1(9Z)/24:1(15Z))

C47H90NO7P (811.645456)

PE(P-18:1(9Z)/24:1(15Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-18:1(9Z)/24:1(15Z)), in particular, consists of one chain of plasmalogen 18:1n9 at the C-1 position and one chain of nervonic acid at the C-2 position. The plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney, while the nervonic acid moiety is derived from fish oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

PE-NMe(18:1(11Z)/22:2(13Z,16Z))

C46H86NO8P (811.6090726)

PE-NMe(18:1(11Z)/22:2(13Z,16Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(18:1(11Z)/22:2(13Z,16Z)), in particular, consists of one chain of cis-vaccenic acid at the C-1 position and one chain of docosadienoic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(18:1(9Z)/22:2(13Z,16Z))

C46H86NO8P (811.6090726)

PE-NMe(18:1(9Z)/22:2(13Z,16Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(18:1(9Z)/22:2(13Z,16Z)), in particular, consists of one chain of oleic acid at the C-1 position and one chain of docosadienoic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(18:2(9Z,12Z)/22:1(13Z))

C46H86NO8P (811.6090726)

PE-NMe(18:2(9Z,12Z)/22:1(13Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(18:2(9Z,12Z)/22:1(13Z)), in particular, consists of one chain of linoleic acid at the C-1 position and one chain of erucic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(18:3(6Z,9Z,12Z)/22:0)

C46H86NO8P (811.6090726)

PE-NMe(18:3(6Z,9Z,12Z)/22:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(18:3(6Z,9Z,12Z)/22:0), in particular, consists of one chain of gamma-linolenic acid at the C-1 position and one chain of behenic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(18:3(9Z,12Z,15Z)/22:0)

C46H86NO8P (811.6090726)

PE-NMe(18:3(9Z,12Z,15Z)/22:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(18:3(9Z,12Z,15Z)/22:0), in particular, consists of one chain of alpha-linolenic acid at the C-1 position and one chain of behenic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(20:0/20:3(5Z,8Z,11Z))

C46H86NO8P (811.6090726)

PE-NMe(20:0/20:3(5Z,8Z,11Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(20:0/20:3(5Z,8Z,11Z)), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of mead acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(20:0/20:3(8Z,11Z,14Z))

C46H86NO8P (811.6090726)

PE-NMe(20:0/20:3(8Z,11Z,14Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(20:0/20:3(8Z,11Z,14Z)), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of dihomo-gamma-linolenic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(20:1(11Z)/20:2(11Z,14Z))

C46H86NO8P (811.6090726)

PE-NMe(20:1(11Z)/20:2(11Z,14Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(20:1(11Z)/20:2(11Z,14Z)), in particular, consists of one chain of eicosenoic acid at the C-1 position and one chain of eicosadienoic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(20:2(11Z,14Z)/20:1(11Z))

C46H86NO8P (811.6090726)

PE-NMe(20:2(11Z,14Z)/20:1(11Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(20:2(11Z,14Z)/20:1(11Z)), in particular, consists of one chain of eicosadienoic acid at the C-1 position and one chain of eicosenoic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(20:3(5Z,8Z,11Z)/20:0)

C46H86NO8P (811.6090726)

PE-NMe(20:3(5Z,8Z,11Z)/20:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(20:3(5Z,8Z,11Z)/20:0), in particular, consists of one chain of mead acid at the C-1 position and one chain of arachidic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(20:3(8Z,11Z,14Z)/20:0)

C46H86NO8P (811.6090726)

PE-NMe(20:3(8Z,11Z,14Z)/20:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(20:3(8Z,11Z,14Z)/20:0), in particular, consists of one chain of dihomo-gamma-linolenic acid at the C-1 position and one chain of arachidic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(22:0/18:3(6Z,9Z,12Z))

C46H86NO8P (811.6090726)

PE-NMe(22:0/18:3(6Z,9Z,12Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(22:0/18:3(6Z,9Z,12Z)), in particular, consists of one chain of behenic acid at the C-1 position and one chain of gamma-linolenic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(22:0/18:3(9Z,12Z,15Z))

C46H86NO8P (811.6090726)

PE-NMe(22:0/18:3(9Z,12Z,15Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(22:0/18:3(9Z,12Z,15Z)), in particular, consists of one chain of behenic acid at the C-1 position and one chain of alpha-linolenic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(22:1(13Z)/18:2(9Z,12Z))

C46H86NO8P (811.6090726)

PE-NMe(22:1(13Z)/18:2(9Z,12Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(22:1(13Z)/18:2(9Z,12Z)), in particular, consists of one chain of erucic acid at the C-1 position and one chain of linoleic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(22:2(13Z,16Z)/18:1(11Z))

C46H86NO8P (811.6090726)

PE-NMe(22:2(13Z,16Z)/18:1(11Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(22:2(13Z,16Z)/18:1(11Z)), in particular, consists of one chain of docosadienoic acid at the C-1 position and one chain of cis-vaccenic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(22:2(13Z,16Z)/18:1(9Z))

C46H86NO8P (811.6090726)

PE-NMe(22:2(13Z,16Z)/18:1(9Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(22:2(13Z,16Z)/18:1(9Z)), in particular, consists of one chain of docosadienoic acid at the C-1 position and one chain of oleic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PC(P-18:0/20:3(6,8,11)-OH(5))

C46H86NO8P (811.6090726)

PC(P-18:0/20:3(6,8,11)-OH(5)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(P-18:0/20:3(6,8,11)-OH(5)), in particular, consists of one chain of one 1Z-octadecenyl at the C-1 position and one chain of 5-hydroxyeicosatetrienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(20:3(6,8,11)-OH(5)/P-18:0)

C46H86NO8P (811.6090726)

PC(20:3(6,8,11)-OH(5)/P-18:0) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(20:3(6,8,11)-OH(5)/P-18:0), in particular, consists of one chain of one 5-hydroxyeicosatetrienoyl at the C-1 position and one chain of 1Z-octadecenyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

Phosphatidylcholine 18:0-20:3

C46H86NO8P (811.6090726)

PC(18:0e/14,15-EET)

C46H86NO8P (811.6090726)

PC(18:0e/18-HETE)

C46H86NO8P (811.6090726)

PC(18:0e/20-HETE)

C46H86NO8P (811.6090726)

PC(18:0e/8-HETE)

C46H86NO8P (811.6090726)

PC 38:3

C46H86NO8P (811.6090726)

Found in mouse small intestine; TwoDicalId=310; MgfFile=160907_Small_Intestine_EPA_Neg_08; MgfId=1511

PC(16:0/22:3)[U]

C46H86NO8P (811.6090726)

PC(18:0/20:3)[U]

C46H86NO8P (811.6090726)

PC(18:0/20:3)

C46H86NO8P (811.6090726)

PC(18:2/20:1)

C46H86NO8P (811.6090726)

1-(9Z,1Z-octadecadienoyl)-2-(10Z,13Z,16Z,19Z-docosatetraenoyl)-3-O-[hydroxymethyl-N,N,N-trimethyl-beta-alanine]-glycerol

C50H85NO7 (811.63257)

Lecithin

C46H86NO8P (811.6090726)

PE(42:2)

C47H90NO7P (811.645456)

PE(19:1(9Z)/22:2(13Z,16Z))

C46H86NO8P (811.6090726)

PE(20:3(8Z,11Z,14Z)/21:0)

C46H86NO8P (811.6090726)

PE(21:0/20:3(8Z,11Z,14Z))

C46H86NO8P (811.6090726)

PE(22:2(13Z,16Z)/19:1(9Z))

C46H86NO8P (811.6090726)

PE(P-20:0/22:2(13Z,16Z))

C47H90NO7P (811.645456)

PE 41:3

C46H86NO8P (811.6090726)

PE O-42:3

C47H90NO7P (811.645456)

[2-[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]oxy-3-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

octaprenylphospho-beta-D-mannose

C46H84O9P- (811.5852644)

PC(P-18:0/20:3(6,8,11)-OH(5))

C46H86NO8P (811.6090726)

PC(20:3(6,8,11)-OH(5)/P-18:0)

C46H86NO8P (811.6090726)

2-[[(E,2S,3R)-2-[[(5R,6Z,8E,10E,12S,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoyl]amino]-3-hydroxyicos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C45H84N2O8P+ (811.5964974000001)

2-[[(E,2S,3R)-2-[[(5S,6E,8Z,11Z,13E,15R)-5,15-dihydroxyicosa-6,8,11,13-tetraenoyl]amino]-3-hydroxyicos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C45H84N2O8P+ (811.5964974000001)

2-[[(E,2S,3R)-2-[[(5R,6R,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoyl]amino]-3-hydroxyicos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C45H84N2O8P+ (811.5964974000001)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propan-2-yl] (Z)-tetracos-13-enoate

C47H90NO7P (811.645456)

[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-[(Z)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

Ldgcc 40:7

C50H85NO7 (811.63257)

HexCer 9:0;2O/34:8

C49H81NO8 (811.5961866)

HexCer 9:1;2O/34:7

C49H81NO8 (811.5961866)

HexCer 17:3;2O/26:5

C49H81NO8 (811.5961866)

HexCer 11:1;2O/32:7

C49H81NO8 (811.5961866)

HexCer 13:2;2O/30:6

C49H81NO8 (811.5961866)

HexCer 17:1;2O/26:7

C49H81NO8 (811.5961866)

HexCer 15:3;2O/28:5

C49H81NO8 (811.5961866)

HexCer 19:3;2O/24:5

C49H81NO8 (811.5961866)

HexCer 25:3;2O/18:5

C49H81NO8 (811.5961866)

HexCer 17:2;2O/26:6

C49H81NO8 (811.5961866)

HexCer 13:1;2O/30:7

C49H81NO8 (811.5961866)

HexCer 11:0;2O/32:8

C49H81NO8 (811.5961866)

HexCer 21:3;2O/22:5

C49H81NO8 (811.5961866)

HexCer 23:3;2O/20:5

C49H81NO8 (811.5961866)

HexCer 15:1;2O/28:7

C49H81NO8 (811.5961866)

HexCer 15:2;2O/28:6

C49H81NO8 (811.5961866)

HexCer 19:2;2O/24:6

C49H81NO8 (811.5961866)

HexCer 21:2;2O/22:6

C49H81NO8 (811.5961866)

HexCer 13:0;2O/30:8

C49H81NO8 (811.5961866)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (28Z,31Z,34Z)-dotetraconta-28,31,34-trienoate

C47H90NO7P (811.645456)

[2-[(14Z,17Z,20Z)-octacosa-14,17,20-trienoyl]oxy-3-undecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO7P (811.645456)

2-[3-nonanoyloxy-2-[(9Z,12Z,15Z,18Z,21Z,24Z,27Z)-triaconta-9,12,15,18,21,24,27-heptaenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C49H81NO8 (811.5961866)

Lnape 15:1/N-26:2

C46H86NO8P (811.6090726)

Lnape 20:1/N-21:2

C46H86NO8P (811.6090726)

Lnape 17:0/N-24:3

C46H86NO8P (811.6090726)

Lnape 24:1/N-17:2

C46H86NO8P (811.6090726)

Lnape 25:0/N-16:3

C46H86NO8P (811.6090726)

Lnape 22:2/N-19:1

C46H86NO8P (811.6090726)

Lnape 22:1/N-19:2

C46H86NO8P (811.6090726)

Lnape 15:0/N-26:3

C46H86NO8P (811.6090726)

Lnape 26:2/N-15:1

C46H86NO8P (811.6090726)

Lnape 21:0/N-20:3

C46H86NO8P (811.6090726)

Lnape 18:3/N-23:0

C46H86NO8P (811.6090726)

Lnape 21:2/N-20:1

C46H86NO8P (811.6090726)

Lnape 19:0/N-22:3

C46H86NO8P (811.6090726)

Lnape 17:2/N-24:1

C46H86NO8P (811.6090726)

Lnape 17:1/N-24:2

C46H86NO8P (811.6090726)

Lnape 19:1/N-22:2

C46H86NO8P (811.6090726)

Lnape 20:3/N-21:0

C46H86NO8P (811.6090726)

Lnape 20:2/N-21:1

C46H86NO8P (811.6090726)

Lnape 24:3/N-17:0

C46H86NO8P (811.6090726)

Lnape 26:3/N-15:0

C46H86NO8P (811.6090726)

Lnape 22:3/N-19:0

C46H86NO8P (811.6090726)

Lnape 24:2/N-17:1

C46H86NO8P (811.6090726)

Lnape 19:2/N-22:1

C46H86NO8P (811.6090726)

Lnape 21:1/N-20:2

C46H86NO8P (811.6090726)

Lnape 23:0/N-18:3

C46H86NO8P (811.6090726)

Lnape 16:3/N-25:0

C46H86NO8P (811.6090726)

2-[2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxy-3-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C49H81NO8 (811.5961866)

2-[3-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C49H81NO8 (811.5961866)

2-[2-[(8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C49H81NO8 (811.5961866)

2-[2-[(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoyl]oxy-3-tridecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C49H81NO8 (811.5961866)

2-[2-[(7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoyl]oxy-3-undecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C49H81NO8 (811.5961866)

2-[3-[(Z)-pentadec-9-enoyl]oxy-2-[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C49H81NO8 (811.5961866)

2-[2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C49H81NO8 (811.5961866)

2-[2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-[(Z)-heptadec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C49H81NO8 (811.5961866)

HexCer 20:3;3O/20:0;(2OH)

C46H85NO10 (811.617315)

HexCer 19:3;3O/21:0;(2OH)

C46H85NO10 (811.617315)

HexCer 25:3;3O/15:0;(2OH)

C46H85NO10 (811.617315)

HexCer 26:3;3O/14:0;(2OH)

C46H85NO10 (811.617315)

HexCer 21:3;3O/19:0;(2OH)

C46H85NO10 (811.617315)

HexCer 27:3;3O/13:0;(2OH)

C46H85NO10 (811.617315)

HexCer 28:3;3O/12:0;(2OH)

C46H85NO10 (811.617315)

HexCer 24:3;3O/16:0;(2OH)

C46H85NO10 (811.617315)

HexCer 23:3;3O/17:0;(2OH)

C46H85NO10 (811.617315)

HexCer 22:3;3O/18:0;(2OH)

C46H85NO10 (811.617315)

HexCer 18:3;3O/22:0;(2OH)

C46H85NO10 (811.617315)

HexCer 12:1;3O/28:2;(2OH)

C46H85NO10 (811.617315)

(4E,8E)-2-[[(8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoyl]amino]-3-hydroxytetracosa-4,8-diene-1-sulfonic acid

C50H85NO5S (811.6148119999999)

(4E,8E,12E)-2-[[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]amino]-3-hydroxytetracosa-4,8,12-triene-1-sulfonic acid

C50H85NO5S (811.6148119999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propan-2-yl] (Z)-docos-13-enoate

C47H90NO7P (811.645456)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(17Z,20Z)-octacosa-17,20-dienoxy]propan-2-yl] (Z)-tetradec-9-enoate

C47H90NO7P (811.645456)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]propan-2-yl] hexacosanoate

C47H90NO7P (811.645456)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octadecoxypropan-2-yl] (10Z,13Z,16Z)-tetracosa-10,13,16-trienoate

C47H90NO7P (811.645456)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propan-2-yl] (Z)-octadec-9-enoate

C47H90NO7P (811.645456)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(14Z,17Z,20Z)-octacosa-14,17,20-trienoxy]propan-2-yl] tetradecanoate

C47H90NO7P (811.645456)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-icos-11-enoxy]propan-2-yl] (13Z,16Z)-docosa-13,16-dienoate

C47H90NO7P (811.645456)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-henicos-11-enoxy]propan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate

C47H90NO7P (811.645456)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-hexacos-15-enoxy]propan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

C47H90NO7P (811.645456)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-docosoxypropan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate

C47H90NO7P (811.645456)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecoxypropan-2-yl] (12Z,15Z,18Z)-hexacosa-12,15,18-trienoate

C47H90NO7P (811.645456)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecoxypropan-2-yl] (14Z,17Z,20Z)-octacosa-14,17,20-trienoate

C47H90NO7P (811.645456)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-docos-13-enoxy]propan-2-yl] (11Z,14Z)-icosa-11,14-dienoate

C47H90NO7P (811.645456)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-icosoxypropan-2-yl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate

C47H90NO7P (811.645456)

(4E,8E,12E)-3-hydroxy-2-[[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]amino]hexacosa-4,8,12-triene-1-sulfonic acid

C50H85NO5S (811.6148119999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(15Z,18Z)-hexacosa-15,18-dienoxy]propan-2-yl] (Z)-hexadec-9-enoate

C47H90NO7P (811.645456)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoxy]propan-2-yl] octadecanoate

C47H90NO7P (811.645456)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(13Z,16Z)-docosa-13,16-dienoxy]propan-2-yl] (Z)-icos-11-enoate

C47H90NO7P (811.645456)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetracosoxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C47H90NO7P (811.645456)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoxy]propan-2-yl] hexadecanoate

C47H90NO7P (811.645456)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] (17Z,20Z)-octacosa-17,20-dienoate

C47H90NO7P (811.645456)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z)-henicosa-11,14-dienoxy]propan-2-yl] (Z)-henicos-11-enoate

C47H90NO7P (811.645456)

(E)-2-[[(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoyl]amino]-3-hydroxytetracos-4-ene-1-sulfonic acid

C50H85NO5S (811.6148119999999)

(4E,8E)-3-hydroxy-2-[[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoyl]amino]hexacosa-4,8-diene-1-sulfonic acid

C50H85NO5S (811.6148119999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tetracos-13-enoxy]propan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

C47H90NO7P (811.645456)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexacosoxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C47H90NO7P (811.645456)

[3-[(15Z,18Z)-hexacosa-15,18-dienoxy]-2-[(Z)-tridec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO7P (811.645456)

[2-pentadecanoyloxy-3-[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO7P (811.645456)

[2-[(Z)-icos-11-enoyl]oxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO7P (811.645456)

[3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-2-tricosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO7P (811.645456)

[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-[(Z)-nonadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO7P (811.645456)

[3-[(Z)-docos-13-enoxy]-2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO7P (811.645456)

[2-[(Z)-docos-13-enoyl]oxy-3-[(9Z,12Z)-heptadeca-9,12-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO7P (811.645456)

[3-[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoxy]-2-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO7P (811.645456)

[3-[(Z)-icos-11-enoxy]-2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO7P (811.645456)

[2-[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]oxy-3-nonadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO7P (811.645456)

[3-[(14Z,17Z,20Z)-octacosa-14,17,20-trienoxy]-2-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO7P (811.645456)

[2-[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]oxy-3-tridecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO7P (811.645456)

[2-[(15Z,18Z)-hexacosa-15,18-dienoyl]oxy-3-[(Z)-tridec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO7P (811.645456)

[2-[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]oxy-3-heptadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO7P (811.645456)

[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-tricosoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO7P (811.645456)

[3-[(13Z,16Z)-docosa-13,16-dienoxy]-2-[(Z)-heptadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO7P (811.645456)

[3-pentadecoxy-2-[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO7P (811.645456)

[3-[(11Z,14Z)-icosa-11,14-dienoxy]-2-[(Z)-nonadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO7P (811.645456)

[3-henicosoxy-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO7P (811.645456)

[2-[(Z)-pentadec-9-enoyl]oxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO7P (811.645456)

[3-[(Z)-pentadec-9-enoxy]-2-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO7P (811.645456)

[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-[(Z)-heptadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO7P (811.645456)

[3-[(Z)-henicos-11-enoxy]-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO7P (811.645456)

[3-[(11Z,14Z)-henicosa-11,14-dienoxy]-2-[(Z)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO7P (811.645456)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (14Z,17Z,20Z)-octacosa-14,17,20-trienoate

C46H86NO8P (811.6090726)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] (16Z,19Z,22Z)-triaconta-16,19,22-trienoate

C46H86NO8P (811.6090726)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] (10Z,13Z,16Z)-tetracosa-10,13,16-trienoate

C46H86NO8P (811.6090726)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (17Z,20Z)-octacosa-17,20-dienoate

C46H86NO8P (811.6090726)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] (12Z,15Z,18Z)-hexacosa-12,15,18-trienoate

C46H86NO8P (811.6090726)

OxPC 38:3e+1O(1Cyc)

C46H86NO8P (811.6090726)

4-[2,3-bis[[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]oxy]propoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

4-[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

4-[2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-octadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

4-[3-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

4-[2-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]oxy-3-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

4-[3-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

4-[2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-[(Z)-octadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

4-[2-[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]oxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

4-[2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxy-3-[(Z)-icos-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

4-[3-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-2-[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

4-[3-[(Z)-docos-13-enoyl]oxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

HexCer 24:1;3O/16:2;(2OH)

C46H85NO10 (811.617315)

HexCer 19:2;3O/21:1;(2OH)

C46H85NO10 (811.617315)

HexCer 17:2;3O/23:1;(2OH)

C46H85NO10 (811.617315)

HexCer 25:2;3O/15:1;(2OH)

C46H85NO10 (811.617315)

HexCer 27:2;3O/13:1;(2OH)

C46H85NO10 (811.617315)

HexCer 16:2;3O/24:1;(2OH)

C46H85NO10 (811.617315)

HexCer 14:1;3O/26:2;(2OH)

C46H85NO10 (811.617315)

HexCer 16:1;3O/24:2;(2OH)

C46H85NO10 (811.617315)

HexCer 18:2;3O/22:1;(2OH)

C46H85NO10 (811.617315)

HexCer 22:2;3O/18:1;(2OH)

C46H85NO10 (811.617315)

HexCer 20:1;3O/20:2;(2OH)

C46H85NO10 (811.617315)

HexCer 20:2;3O/20:1;(2OH)

C46H85NO10 (811.617315)

HexCer 21:2;3O/19:1;(2OH)

C46H85NO10 (811.617315)

HexCer 28:2;3O/12:1;(2OH)

C46H85NO10 (811.617315)

HexCer 22:1;3O/18:2;(2OH)

C46H85NO10 (811.617315)

HexCer 15:2;3O/25:1;(2OH)

C46H85NO10 (811.617315)

HexCer 14:2;3O/26:1;(2OH)

C46H85NO10 (811.617315)

HexCer 24:2;3O/16:1;(2OH)

C46H85NO10 (811.617315)

HexCer 18:1;3O/22:2;(2OH)

C46H85NO10 (811.617315)

HexCer 26:2;3O/14:1;(2OH)

C46H85NO10 (811.617315)

[2-[(5Z,8Z,10Z)-12-hydroxyicosa-5,8,10-trienoyl]oxy-3-[(Z)-octadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-octadec-9-enoxy]propan-2-yl] (13Z,16Z)-tetracosa-13,16-dienoate

C47H90NO7P (811.645456)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-hexadeca-9,12-dienoxy]propan-2-yl] (Z)-hexacos-15-enoate

C47H90NO7P (811.645456)

[3-[(10Z,13Z,16Z)-docosa-10,13,16-trienoxy]-2-heptadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO7P (811.645456)

[2-henicosanoyloxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO7P (811.645456)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-hexadec-9-enoxy]propan-2-yl] (15Z,18Z)-hexacosa-15,18-dienoate

C47H90NO7P (811.645456)

[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-[(Z)-octadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO7P (811.645456)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propan-2-yl] tetracosanoate

C47H90NO7P (811.645456)

[3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]-2-nonadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO7P (811.645456)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]propan-2-yl] docosanoate

C47H90NO7P (811.645456)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(10Z,13Z,16Z)-docosa-10,13,16-trienoxy]propan-2-yl] icosanoate

C47H90NO7P (811.645456)

[2-[(Z)-henicos-11-enoyl]oxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO7P (811.645456)

[3-octanoyloxy-2-[(16Z,19Z,22Z)-triaconta-16,19,22-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] (18Z,21Z,24Z)-dotriaconta-18,21,24-trienoate

C46H86NO8P (811.6090726)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-icos-11-enoyl]oxypropan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate

C46H86NO8P (811.6090726)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]oxypropyl] henicosanoate

C46H86NO8P (811.6090726)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-nonadec-9-enoyl]oxypropan-2-yl] (13Z,16Z)-docosa-13,16-dienoate

C46H86NO8P (811.6090726)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxypropyl] pentacosanoate

C46H86NO8P (811.6090726)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonadecanoyloxypropan-2-yl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate

C46H86NO8P (811.6090726)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxypropyl] tricosanoate

C46H86NO8P (811.6090726)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropyl] (Z)-docos-13-enoate

C46H86NO8P (811.6090726)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropyl] (Z)-henicos-11-enoate

C46H86NO8P (811.6090726)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxypropyl] (Z)-tetracos-13-enoate

C46H86NO8P (811.6090726)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropan-2-yl] (15Z,18Z)-hexacosa-15,18-dienoate

C46H86NO8P (811.6090726)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-heptadec-9-enoyl]oxypropan-2-yl] (13Z,16Z)-tetracosa-13,16-dienoate

C46H86NO8P (811.6090726)

[3-decanoyloxy-2-[(14Z,17Z,20Z)-octacosa-14,17,20-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

[3-dodecanoyloxy-2-[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

[2-[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]oxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

[3-icosanoyloxy-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

[3-[(Z)-icos-11-enoyl]oxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

[3-[(Z)-henicos-11-enoyl]oxy-2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

[2-[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]oxy-3-hexadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-[(Z)-heptadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

[2-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-[(Z)-hexadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

[3-docosanoyloxy-2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

[3-[(Z)-docos-13-enoyl]oxy-2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-[(Z)-nonadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

[2-[(6E,8E,11E,14E)-5-hydroxyicosa-6,8,11,14-tetraenoyl]oxy-3-octadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

[(2R)-2-[(13E,16E)-docosa-13,16-dienoyl]oxy-3-[(E)-hexadec-7-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

4-[3-[(17E,20E,23E)-hexacosa-17,20,23-trienoyl]oxy-2-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

[(2R)-2-[(E)-icos-13-enoyl]oxy-3-[(2E,4E)-octadeca-2,4-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

4-[2-[(E)-henicos-9-enoyl]oxy-3-[(4E,7E,10E,13E,16E)-nonadeca-4,7,10,13,16-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-pentadec-9-enoyl]oxypropyl] (5E,9E)-hexacosa-5,9-dienoate

C46H86NO8P (811.6090726)

4-[2-[(7E,9E,11E,13E,15E,17E)-icosa-7,9,11,13,15,17-hexaenoyl]oxy-3-icosanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

[(2R)-2-icosanoyloxy-3-[(9E,12E,15E)-octadeca-9,12,15-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

4-[3-[(13E,16E,19E,22E)-pentacosa-13,16,19,22-tetraenoyl]oxy-2-[(9E,12E)-pentadeca-9,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

4-[3-[(9E,11E,13E,15E)-henicosa-9,11,13,15-tetraenoyl]oxy-2-[(7E,9E)-nonadeca-7,9-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

[(2R)-3-icosanoyloxy-2-[(6E,9E,12E)-octadeca-6,9,12-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

4-[2-[(E)-hexadec-7-enoyl]oxy-3-[(6E,9E,12E,15E,18E)-tetracosa-6,9,12,15,18-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

[(2R)-2-[(5E,8E)-icosa-5,8-dienoyl]oxy-3-octadec-17-enoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

4-[2-[(4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-octadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

[(2R)-2-[(11E,14E)-icosa-11,14-dienoyl]oxy-3-[(E)-octadec-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

4-[3-[(11E,14E)-heptadeca-11,14-dienoyl]oxy-2-[(11E,14E,17E,20E)-tricosa-11,14,17,20-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

4-[2-[(11E,14E,17E,20E,23E)-hexacosa-11,14,17,20,23-pentaenoyl]oxy-3-[(E)-tetradec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

[(2R)-3-[(E)-icos-11-enoyl]oxy-2-[(9E,11E)-octadeca-9,11-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

4-[3-[(14E,17E,20E,23E)-hexacosa-14,17,20,23-tetraenoyl]oxy-2-[(7E,9E)-tetradeca-7,9-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

4-[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-[(E)-tetracos-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

[(2R)-2-[(E)-icos-11-enoyl]oxy-3-[(9E,11E)-octadeca-9,11-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

[(2S)-3-[(13E,16E)-docosa-13,16-dienoyl]oxy-2-[(E)-hexadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

[(2R)-2-[(5E,8E)-icosa-5,8-dienoyl]oxy-3-[(E)-octadec-6-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

[(2R)-2-[(5E,8E)-icosa-5,8-dienoyl]oxy-3-[(E)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

[(2S)-3-[(13E,16E)-docosa-13,16-dienoyl]oxy-2-[(E)-hexadec-7-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

4-[2-[(11E,14E)-icosa-11,14-dienoyl]oxy-3-[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

4-[3-[(8E,11E,14E,17E,20E,23E)-hexacosa-8,11,14,17,20,23-hexaenoyl]oxy-2-tetradecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

4-[2-[(13E,16E,19E,22E)-pentacosa-13,16,19,22-tetraenoyl]oxy-3-[(9E,12E)-pentadeca-9,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

4-[3-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-2-[(15E,18E,21E)-tetracosa-15,18,21-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

4-[2,3-bis[[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxy]propoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

[(2R)-2-[(13E,16E)-docosa-13,16-dienoyl]oxy-3-[(E)-hexadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

[(2R)-3-[(11E,14E)-icosa-11,14-dienoyl]oxy-2-octadec-17-enoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

[(2R)-3-[(E)-icos-11-enoyl]oxy-2-[(2E,4E)-octadeca-2,4-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

4-[2-[(9E,11E,13E,15E)-henicosa-9,11,13,15-tetraenoyl]oxy-3-[(7E,9E)-nonadeca-7,9-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(8E,11E,14E)-icosa-8,11,14-trienoyl]oxypropan-2-yl] henicosanoate

C46H86NO8P (811.6090726)

[(2R)-2-[(11E,14E)-icosa-11,14-dienoyl]oxy-3-[(E)-octadec-7-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

4-[3-[(4E,7E)-hexadeca-4,7-dienoyl]oxy-2-[(9E,12E,15E,18E)-tetracosa-9,12,15,18-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9E,12E)-heptadeca-9,12-dienoyl]oxypropan-2-yl] (E)-tetracos-15-enoate

C46H86NO8P (811.6090726)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(4E,7E)-hexadeca-4,7-dienoyl]oxypropyl] (E)-pentacos-11-enoate

C46H86NO8P (811.6090726)

[(2R)-3-[(E)-icos-11-enoyl]oxy-2-[(9E,12E)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

4-[3-[(5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoyl]oxy-2-[(E)-icos-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

[(2R)-2-[(E)-icos-13-enoyl]oxy-3-[(6E,9E)-octadeca-6,9-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

[(2R)-3-[(11E,14E)-icosa-11,14-dienoyl]oxy-2-[(E)-octadec-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

4-[3-heptadecanoyloxy-2-[(5E,8E,11E,14E,17E,20E)-tricosa-5,8,11,14,17,20-hexaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

[(2R)-3-[(E)-icos-13-enoyl]oxy-2-[(9E,11E)-octadeca-9,11-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

[(2R)-2-[(5E,8E)-icosa-5,8-dienoyl]oxy-3-[(E)-octadec-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

4-[3-hexadecanoyloxy-2-[(6E,9E,12E,15E,18E,21E)-tetracosa-6,9,12,15,18,21-hexaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

4-[2-[(E)-docos-11-enoyl]oxy-3-[(7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(6E,9E,12E)-octadeca-6,9,12-trienoyl]oxypropan-2-yl] tricosanoate

C46H86NO8P (811.6090726)

4-[2-[(9E,11E)-henicosa-9,11-dienoyl]oxy-3-[(7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

4-[2-[(13E,16E,19E)-docosa-13,16,19-trienoyl]oxy-3-[(11E,13E,15E)-octadeca-11,13,15-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

[(2R)-3-[(5E,8E)-icosa-5,8-dienoyl]oxy-2-[(E)-octadec-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

4-[3-[(7E,10E,13E,16E,19E)-docosa-7,10,13,16,19-pentaenoyl]oxy-2-[(E)-octadec-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

[(2R)-2-[(11E,14E)-icosa-11,14-dienoyl]oxy-3-[(E)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

[(2R)-3-[(E)-icos-13-enoyl]oxy-2-[(6E,9E)-octadeca-6,9-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

[(2R)-2-[(11E,14E)-icosa-11,14-dienoyl]oxy-3-[(E)-octadec-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

[(2R)-3-[(E)-icos-13-enoyl]oxy-2-[(2E,4E)-octadeca-2,4-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

4-[3-[(14E,16E)-docosa-14,16-dienoyl]oxy-2-[(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

4-[2-[(14E,16E)-docosa-14,16-dienoyl]oxy-3-[(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

[(2R)-3-[(11E,14E)-icosa-11,14-dienoyl]oxy-2-[(E)-octadec-4-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

4-[2-[(E)-heptadec-7-enoyl]oxy-3-[(8E,11E,14E,17E,20E)-tricosa-8,11,14,17,20-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

4-[2-[(9E,11E,13E,15E,17E)-henicosa-9,11,13,15,17-pentaenoyl]oxy-3-[(E)-nonadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

4-[3-[(E)-docos-11-enoyl]oxy-2-[(7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

4-[3-[(10E,13E,16E,19E)-docosa-10,13,16,19-tetraenoyl]oxy-2-[(10E,12E)-octadeca-10,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

[(2R)-2-[(5E,8E)-icosa-5,8-dienoyl]oxy-3-[(E)-octadec-4-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

4-[3-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-2-[(18E,21E)-tetracosa-18,21-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

[(2R)-2-[(11E,14E)-icosa-11,14-dienoyl]oxy-3-[(E)-octadec-4-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

[(2R)-2-[(E)-icos-11-enoyl]oxy-3-[(2E,4E)-octadeca-2,4-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

4-[2-[(8E,11E,14E)-heptadeca-8,11,14-trienoyl]oxy-3-[(14E,17E,20E)-tricosa-14,17,20-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(9E,12E,15E)-octadeca-9,12,15-trienoyl]oxypropyl] tricosanoate

C46H86NO8P (811.6090726)

[(2R)-2-[(E)-icos-11-enoyl]oxy-3-[(9E,12E)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

4-[2-[(17E,20E,23E)-hexacosa-17,20,23-trienoyl]oxy-3-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

4-[3-[(11E,14E)-icosa-11,14-dienoyl]oxy-2-[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

[(2R)-3-[(11E,14E)-icosa-11,14-dienoyl]oxy-2-[(E)-octadec-6-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

4-[2-[(8E,11E,14E,17E,20E,23E)-hexacosa-8,11,14,17,20,23-hexaenoyl]oxy-3-tetradecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-icos-1-enoxy]propan-2-yl] (13E,16E)-docosa-13,16-dienoate

C47H90NO7P (811.645456)

[(2R)-3-[(11E,14E)-icosa-11,14-dienoyl]oxy-2-[(E)-octadec-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

[(2R)-2-[(5E,8E)-icosa-5,8-dienoyl]oxy-3-[(E)-octadec-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

4-[2-[(10E,13E,16E,19E)-docosa-10,13,16,19-tetraenoyl]oxy-3-[(10E,12E)-octadeca-10,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

4-[2-[(10E,13E,16E,19E,22E)-pentacosa-10,13,16,19,22-pentaenoyl]oxy-3-[(E)-pentadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

[(2R)-3-[(11E,14E)-icosa-11,14-dienoyl]oxy-2-[(E)-octadec-7-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

[(2R)-3-[(E)-icos-13-enoyl]oxy-2-[(9E,12E)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

4-[3-[(E)-hexadec-7-enoyl]oxy-2-[(6E,9E,12E,15E,18E)-tetracosa-6,9,12,15,18-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

[(2R)-2-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxy-3-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

[(2R)-3-[(5E,8E)-icosa-5,8-dienoyl]oxy-2-[(E)-octadec-6-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

[(2R)-2-[(11E,14E)-icosa-11,14-dienoyl]oxy-3-octadec-17-enoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxypropyl] henicosanoate

C46H86NO8P (811.6090726)

4-[3-[(4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-2-octadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

4-[2-heptadecanoyloxy-3-[(5E,8E,11E,14E,17E,20E)-tricosa-5,8,11,14,17,20-hexaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

[(2R)-2-[(E)-icos-13-enoyl]oxy-3-[(9E,11E)-octadeca-9,11-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

4-[3-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-2-[(E)-tetracos-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

4-[2-[(13E,16E,19E)-pentacosa-13,16,19-trienoyl]oxy-3-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

4-[3-[(13E,16E,19E)-pentacosa-13,16,19-trienoyl]oxy-2-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

4-[3-[(7E,9E,11E,13E,15E,17E)-icosa-7,9,11,13,15,17-hexaenoyl]oxy-2-icosanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

4-[2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-[(18E,21E)-tetracosa-18,21-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

4-[3-[(10E,13E,16E,19E,22E)-pentacosa-10,13,16,19,22-pentaenoyl]oxy-2-[(E)-pentadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

4-[2-hexadecanoyloxy-3-[(6E,9E,12E,15E,18E,21E)-tetracosa-6,9,12,15,18,21-hexaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxypropyl] pentacosanoate

C46H86NO8P (811.6090726)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9E,12E,15E)-octadeca-9,12,15-trienoyl]oxypropan-2-yl] tricosanoate

C46H86NO8P (811.6090726)

4-[2-[(5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoyl]oxy-3-[(E)-icos-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

[(2R)-3-[(5E,8E)-icosa-5,8-dienoyl]oxy-2-[(E)-octadec-4-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

[(2R)-3-[(8E,11E,14E)-icosa-8,11,14-trienoyl]oxy-2-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

4-[3-[(7E,10E,13E,16E,19E,22E)-pentacosa-7,10,13,16,19,22-hexaenoyl]oxy-2-pentadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

[(2R)-3-[(5E,8E)-icosa-5,8-dienoyl]oxy-2-[(E)-octadec-7-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-hexadec-1-enoxy]propan-2-yl] (5E,9E)-hexacosa-5,9-dienoate

C47H90NO7P (811.645456)

[(2R)-2-[(8E,11E,14E)-icosa-8,11,14-trienoyl]oxy-3-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

[(2R)-2-[(E)-icos-13-enoyl]oxy-3-[(9E,12E)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

4-[2-[(7E,10E,13E,16E,19E)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-[(E)-octadec-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

[(2R)-3-[(5E,8E)-icosa-5,8-dienoyl]oxy-2-[(E)-octadec-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

4-[2-[(4E,7E)-hexadeca-4,7-dienoyl]oxy-3-[(9E,12E,15E,18E)-tetracosa-9,12,15,18-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

[(2R)-2-[(11E,14E)-icosa-11,14-dienoyl]oxy-3-[(E)-octadec-6-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(6E,9E,12E)-octadeca-6,9,12-trienoyl]oxypropyl] tricosanoate

C46H86NO8P (811.6090726)

4-[2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-[(15E,18E,21E)-tetracosa-15,18,21-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

4-[3-[(9E,11E,13E,15E,17E)-henicosa-9,11,13,15,17-pentaenoyl]oxy-2-[(E)-nonadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

[(2R)-3-[(5E,8E)-icosa-5,8-dienoyl]oxy-2-octadec-17-enoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

4-[2-[(14E,17E,20E,23E)-hexacosa-14,17,20,23-tetraenoyl]oxy-3-[(7E,9E)-tetradeca-7,9-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

4-[3-[(11E,14E,17E,20E,23E)-hexacosa-11,14,17,20,23-pentaenoyl]oxy-2-[(E)-tetradec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(8E,11E,14E)-icosa-8,11,14-trienoyl]oxypropyl] henicosanoate

C46H86NO8P (811.6090726)

[(2R)-2-[(5E,8E)-icosa-5,8-dienoyl]oxy-3-[(E)-octadec-7-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(9E,12E)-heptadeca-9,12-dienoyl]oxypropyl] (E)-tetracos-15-enoate

C46H86NO8P (811.6090726)

4-[3-[(9E,11E,13E)-henicosa-9,11,13-trienoyl]oxy-2-[(10E,13E,16E)-nonadeca-10,13,16-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

4-[2-[(11E,14E)-heptadeca-11,14-dienoyl]oxy-3-[(11E,14E,17E,20E)-tricosa-11,14,17,20-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

4-[3-[(9E,11E)-henicosa-9,11-dienoyl]oxy-2-[(7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

[(2R)-3-[(E)-icos-11-enoyl]oxy-2-[(6E,9E)-octadeca-6,9-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

4-[3-[(E)-heptadec-7-enoyl]oxy-2-[(8E,11E,14E,17E,20E)-tricosa-8,11,14,17,20-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

4-[3-[(8E,11E,14E)-heptadeca-8,11,14-trienoyl]oxy-2-[(14E,17E,20E)-tricosa-14,17,20-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

[(2R)-3-[(5E,8E)-icosa-5,8-dienoyl]oxy-2-[(E)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

4-[2-[(9E,11E,13E)-henicosa-9,11,13-trienoyl]oxy-3-[(10E,13E,16E)-nonadeca-10,13,16-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

[3-docosanoyloxy-2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

4-[3-[(13E,16E,19E)-docosa-13,16,19-trienoyl]oxy-2-[(11E,13E,15E)-octadeca-11,13,15-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

[(2R)-3-[(11E,14E)-icosa-11,14-dienoyl]oxy-2-[(E)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

[3-[(E)-docos-11-enoyl]oxy-2-[(4E,7E)-hexadeca-4,7-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

4-[2-[(7E,10E,13E,16E,19E,22E)-pentacosa-7,10,13,16,19,22-hexaenoyl]oxy-3-pentadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

[(2R)-3-icosanoyloxy-2-[(9E,12E,15E)-octadeca-9,12,15-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxypropan-2-yl] henicosanoate

C46H86NO8P (811.6090726)

4-[3-[(E)-henicos-9-enoyl]oxy-2-[(4E,7E,10E,13E,16E)-nonadeca-4,7,10,13,16-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C50H85NO7 (811.63257)

[(2R)-3-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxy-2-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

[(2R)-2-[(E)-icos-11-enoyl]oxy-3-[(6E,9E)-octadeca-6,9-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

[(2R)-2-icosanoyloxy-3-[(6E,9E,12E)-octadeca-6,9,12-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H86NO8P (811.6090726)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-pentadec-9-enoyl]oxypropan-2-yl] (5E,9E)-hexacosa-5,9-dienoate

C46H86NO8P (811.6090726)

PC(20:0/18:3(9Z,12Z,15Z))

C46H86NO8P (811.6090726)

PC(20:1(11Z)/18:2(9Z,12Z))

C46H86NO8P (811.6090726)

PC(18:0/20:3(8Z,11Z,14Z))

C46H86NO8P (811.6090726)

PC(20:3(8Z,11Z,14Z)/18:0)

C46H86NO8P (811.6090726)

PC(18:0/20:3(5Z,8Z,11Z))

C46H86NO8P (811.6090726)

PC(18:3(6Z,9Z,12Z)/20:0)

C46H86NO8P (811.6090726)

PC(20:0/18:3(6Z,9Z,12Z))

C46H86NO8P (811.6090726)

PC(20:3(5Z,8Z,11Z)/18:0)

C46H86NO8P (811.6090726)

PC(18:3(9Z,12Z,15Z)/20:0)

C46H86NO8P (811.6090726)

PC(18:1(9Z)/20:2(11Z,14Z))

C46H86NO8P (811.6090726)

PC(18:2(9Z,12Z)/20:1(11Z))

C46H86NO8P (811.6090726)

PC(20:2(11Z,14Z)/18:1(9Z))

C46H86NO8P (811.6090726)

PC(22:2(13Z,16Z)/16:1(9Z))

C46H86NO8P (811.6090726)

PC(18:1(11Z)/20:2(11Z,14Z))

C46H86NO8P (811.6090726)

PC(20:2(11Z,14Z)/18:1(11Z))

C46H86NO8P (811.6090726)

PC(16:1(9Z)/22:2(13Z,16Z))

C46H86NO8P (811.6090726)

PE-NMe(22:2(13Z,16Z)/18:1(9Z))

C46H86NO8P (811.6090726)

PE(24:1(15Z)/P-18:1(11Z))

C47H90NO7P (811.645456)

phosphatidylcholine (18:0/20:3)

C46H86NO8P (811.6090726)

A phosphatidylcholine 38:3 in which the fatty acyl groups at positions 1 and 2 are specified as C18:0 and C20:3 respectively.

phosphatidylcholine (18:2/20:1)

C46H86NO8P (811.6090726)

A phosphatidylcholine 38:3 in which the fatty acyl groups at positions 1 and 2 are specified as C18:2 and C20:1 respectively.

phosphatidylcholine 38:3

C46H86NO8P (811.6090726)

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 38 carbons with 3 double bonds.

1-(9Z)-hexadecenoyl-2-(13Z,16Z)-docosadienoyl-sn-glycero-3-phosphocholine

C46H86NO8P (811.6090726)

A phosphatidylcholine in which the acyl groups at C-1 and C-2 are (9Z)-hexadecenoyl and (13Z,16Z)-docosadienoyl respectively.

1-octadecanoyl-2-[(5Z,8Z,11Z)-eicosatrienoyl]-sn-glycero-3-phosphocholine

C46H86NO8P (811.6090726)

A phosphatidylcholine 36:3 in which the acyl groups at positions 1 and 2 are specified as octadecanoyl and (5Z,8Z,11Z)-icosatrienoyl respectively.

1-octadecanoyl-2-[(8Z,11Z,14Z)-eicosatrienoyl]-sn-glycero-3-phosphocholine

C46H86NO8P (811.6090726)

A phosphatidylcholine 38:3 in which the acyl groups specified at positions 1 and 2 are octadecanoyl and (8Z,11Z,14Z)-eicosatrienoyl respectively.

MePC(38:3)

C47H90NO7P (811.645456)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

MePC(37:3)

C46H86NO8P (811.6090726)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

dMePE(39:3)

C46H86NO8P (811.6090726)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

dMePE(40:3)

C47H90NO7P (811.645456)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

DGCC 36:2;O2

C46H85NO10 (811.617315)

DGCC 39:7

C49H81NO8 (811.5961866)

DGTS 39:7;O

C49H81NO8 (811.5961866)

DGTS 40:6

C50H85NO7 (811.63257)

PC O-16:0/22:4;O

C46H86NO8P (811.6090726)

PC O-18:0/20:4;O

C46H86NO8P (811.6090726)

PC O-22:1/17:2

C47H90NO7P (811.645456)

PC O-22:2/17:1

C47H90NO7P (811.645456)

PC O-38:4;O

C46H86NO8P (811.6090726)

PC O-39:3

C47H90NO7P (811.645456)

PC P-18:0/20:3;O

C46H86NO8P (811.6090726)

PC P-18:1/20:2;O

C46H86NO8P (811.6090726)

PC P-20:0/18:3;O

C46H86NO8P (811.6090726)

PC P-20:1/18:2;O

C46H86NO8P (811.6090726)

PC P-22:0/17:2

C47H90NO7P (811.645456)

PC P-22:0/17:2 or PC O-22:1/17:2

C47H90NO7P (811.645456)

PC P-22:1/17:1

C47H90NO7P (811.645456)

PC P-22:1/17:1 or PC O-22:2/17:1

C47H90NO7P (811.645456)

PC P-39:2

C47H90NO7P (811.645456)

PC P-39:2 or PC O-39:3

C47H90NO7P (811.645456)

PC 16:0_22:3

C46H86NO8P (811.6090726)

PC 16:1_22:2

C46H86NO8P (811.6090726)

PC 18:0_20:3

C46H86NO8P (811.6090726)

PC 18:0/20:3

C46H86NO8P (811.6090726)

PC 18:1_20:2

C46H86NO8P (811.6090726)

PC 18:1/20:2

C46H86NO8P (811.6090726)

PC 18:2_20:1

C46H86NO8P (811.6090726)

PC 18:2/20:1

C46H86NO8P (811.6090726)

PC 18:3_20:0

C46H86NO8P (811.6090726)

LNAPE 41:3

C46H86NO8P (811.6090726)

PE O-14:0/28:3

C47H90NO7P (811.645456)

PE O-16:1/26:2

C47H90NO7P (811.645456)

PE O-16:2/26:1

C47H90NO7P (811.645456)

PE O-18:2/24:1

C47H90NO7P (811.645456)

PE O-20:1/22:2

C47H90NO7P (811.645456)

PE O-20:2/22:1

C47H90NO7P (811.645456)

PE O-22:0/20:3

C47H90NO7P (811.645456)

PE O-22:1/20:2

C47H90NO7P (811.645456)

PE O-22:2/20:1

C47H90NO7P (811.645456)

PE O-24:2/18:1

C47H90NO7P (811.645456)

PE P-16:0/26:2

C47H90NO7P (811.645456)

PE P-16:0/26:2 or PE O-16:1/26:2

C47H90NO7P (811.645456)

PE P-16:1/26:1

C47H90NO7P (811.645456)

PE P-16:1/26:1 or PE O-16:2/26:1

C47H90NO7P (811.645456)

PE P-18:1/24:1

C47H90NO7P (811.645456)

PE P-18:1/24:1 or PE O-18:2/24:1

C47H90NO7P (811.645456)

PE P-20:0/22:2

C47H90NO7P (811.645456)

PE P-20:0/22:2 or PE O-20:1/22:2

C47H90NO7P (811.645456)

PE P-20:1/22:1

C47H90NO7P (811.645456)

PE P-20:1/22:1 or PE O-20:2/22:1

C47H90NO7P (811.645456)

PE P-22:0/20:2

C47H90NO7P (811.645456)

PE P-22:0/20:2 or PE O-22:1/20:2

C47H90NO7P (811.645456)

PE P-22:1/20:1

C47H90NO7P (811.645456)

PE P-22:1/20:1 or PE O-22:2/20:1

C47H90NO7P (811.645456)

PE P-24:1/18:1

C47H90NO7P (811.645456)

PE P-24:1/18:1 or PE O-24:2/18:1

C47H90NO7P (811.645456)

PE P-42:2

C47H90NO7P (811.645456)

PE 15:1_26:2

C46H86NO8P (811.6090726)

PE 17:2_24:1

C46H86NO8P (811.6090726)

PE 18:3_23:0

C46H86NO8P (811.6090726)

PE 20:3_21:0

C46H86NO8P (811.6090726)

GalCer 21:2;O2/22:6

C49H81NO8 (811.5961866)

GalCer 43:8;O2

C49H81NO8 (811.5961866)

GlcCer 21:2;O2/22:6

C49H81NO8 (811.5961866)

GlcCer 43:8;O2

C49H81NO8 (811.5961866)

HexCer 21:2;O2/22:6

C49H81NO8 (811.5961866)

HexCer 40:3;O4

C46H85NO10 (811.617315)

HexCer 43:8;O2

C49H81NO8 (811.5961866)